425: ISRL Resolves SPAC Deal Hurdle, Secures BTIG Advisory

Israel Acquisitions Corp. and Gadfin Ltd. resolve a key condition for their business combination, securing BTIG's advisory services and waiver of deferred underwriting fees.

Summary

• Israel Acquisitions Corp (ISRL), Gadfin Ltd., and Israel Acquisitions Sponsor LLC entered into a Letter Agreement on October 14, 2025, to facilitate their Business Combination.
• ISRL also entered into an Advisory Agreement with BTIG, LLC, effective October 10, 2025, for strategic and capital markets advisory services.
• BTIG waived its right to the deferred underwriting commission from the January 12, 2023 underwriting agreement, conditioned on the Business Combination's closing and payment of the Advisory Fee.
• As compensation, BTIG will receive an Advisory Fee of $500,000 in cash from the trust account and 100,000 Class A ordinary shares of ISRL, valued at $10.00 per share, which will convert to NewPubco shares upon closing.
• Israel Acquisitions Sponsor LLC agreed to forfeit an additional 100,000 ordinary shares of ISRL to offset the shares issued to BTIG.
• Gadfin waived its right to terminate the Business Combination Agreement (BCA) that arose from ISRL not receiving a deferred underwriting commission waiver within 30 days of July 2, 2025.
• Prior to closing, NewPubco (the combined company) will arrange a Public Offering of Securities Insurance (POSI) policy to cover BTIG's indemnification claims for six years post-closing, with the cost split 50% between Sponsor and NewPubco.
• BTIG was granted a three-year exclusive right of first refusal to act as lead underwriter for the next special purpose acquisition company (SPAC) initial public offering undertaken by ISRL or the Sponsor, under certain conditions.

Sentiment

Score: 7

Explanation: The filing addresses and resolves a critical condition for the proposed business combination, removing a significant potential impediment to its completion. This is a positive step towards the transaction's success. However, it involves a cash payment and equity issuance, along with a future right of first refusal for BTIG, which represents a cost to the company and its shareholders.

Positives

• Resolution of Gadfin's right to terminate the Business Combination Agreement, removing a significant hurdle for the transaction.
• BTIG's waiver of the deferred underwriting commission, which was a condition for the Business Combination.
• Securing strategic and capital markets advisory services from BTIG for the Business Combination.
• The Sponsor's agreement to forfeit an additional 100,000 ordinary shares of ISRL, mitigating potential dilution from the equity compensation issued to BTIG.

Negatives

• A cash payment of $500,000 from the trust account to BTIG as part of the Advisory Fee.
• Issuance of 100,000 Class A ordinary shares to BTIG, representing a cost to the company, despite the Sponsor's offsetting forfeiture.
• Granting BTIG a three-year exclusive right of first refusal for lead underwriter roles in future SPAC IPOs by ISRL or the Sponsor, potentially limiting future flexibility.
• NewPubco will incur 50% of the cost for a Public Offering of Securities Insurance policy.

Risks

• Changes in domestic and foreign business conditions.
• Changes in the competitive environment in which Gadfin operates.
• Gadfin's ability to manage its growth prospects, meet operational and financial targets, and execute its strategy.
• Impact of economic disruptions, decreased market demand, and other macroeconomic factors, including global pandemics, on Gadfin's business and projected results.
• Gadfin's reliance on its senior management team and key employees.
• Risks related to liquidity, capital resources, and capital expenditures.
• Failure to comply with applicable laws and regulations or changes in the regulatory environment.
• The outcome of any potential litigation, government, and regulatory proceedings, investigations, and inquiries that Gadfin may face.
• Assumptions or analyses used for Gadfin's forecasts proving incorrect, leading to actual operating and financial results significantly below forecasts.
• An acquisition not occurring as planned and negatively affecting operating results.
• The inability of the parties to successfully or timely consummate the Transactions, including risks related to regulatory approvals or shareholder approval.
• The risk that ISRL shareholders could elect to redeem their shares, potentially leaving NewPubco with insufficient cash.
• Failure to realize the anticipated benefits of the Transactions.
• Risks relating to the uncertainty of the projected financial information with respect to Gadfin.
• The effects of competition.
• Changes in applicable laws or regulations.
• The ability of Gadfin to manage expenses and recruit and retain key employees.
• The ability of ISRL or NewPubco to issue equity or equity-linked securities in connection with the Transactions or in the future.
• A potential U.S. government shutdown.
• The impact of certain geopolitical events, including wars in Ukraine, the Israel-Hamas conflict, the Israel-Iran conflict, and broader Middle East conflict.
• The impact of a future pandemic on Gadfin, ISRL, or NewPubco's projected results.

Future Outlook

The parties anticipate successfully consummating the Business Combination. NewPubco is expected to arrange a Public Offering of Securities Insurance policy prior to closing. BTIG will continue to provide strategic and capital markets advisory services and holds a three-year exclusive right of first refusal for lead underwriter roles in future SPAC initial public offerings by ISRL or the Sponsor.

Management Comments

• Gadfin consented to IAC's entry into an advisory agreement with BTIG, LLC, where BTIG will serve as capital markets advisor and waive IAC's deferred underwriting fee in exchange for an advisory fee upon the closing of the Business Combination.
• Gadfin agreed that the Advisory Agreement satisfies the requirement under the Business Combination Agreement and waived its related termination rights.
• BTIG agreed that upon the consummation of the Business Combination, it will enter into an amendment to the Underwriting Agreement to waive the right to payment of the Deferred Underwriting Commission in full, provided such waiver is effective and conditioned upon the payment of BTIG's Advisory Fee in full.

Industry Context

This filing reflects common practices in the SPAC market where complex financial arrangements and advisory roles are crucial for de-SPAC transactions. The waiver of deferred underwriting fees, often a significant liability for SPACs, is a frequent negotiation point, typically in exchange for new advisory agreements or other compensation. The inclusion of a Public Offering of Securities Insurance (POSI) policy highlights the increasing focus on indemnification and risk mitigation for advisors in SPAC transactions. The grant of a right of first refusal for future SPAC IPOs indicates an ongoing relationship between the SPAC sponsor and the investment bank, a common strategy to secure future deal flow.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results. It states that the terms for BTIG's future engagement as lead underwriter for subsequent SPAC IPOs by ISRL or the Sponsor 'shall be substantially consistent with such fees that were charged by BTIG to its clients to act as lead managing underwriter and/or lead bookrunner in connection with the initial public offering of a special purpose acquisition company in the five (5) such publicly filed transactions immediately preceding the execution of the engagement letter.' This refers to a standard for future engagements, not a comparison of current results.

Legal Proceedings

• The filing identifies "the outcome of any potential litigation, government and regulatory proceedings, investigations and inquiries that Gadfin may face" as a risk factor.

Related Party Transactions

• The Letter Agreement was entered into by ISRL, Israel Acquisitions Sponsor LLC (the Sponsor), and Gadfin Ltd. The Sponsor is a related party to ISRL.
• The Advisory Agreement was entered into by ISRL, the Sponsor, and BTIG, LLC. BTIG was the underwriter for ISRL's initial public offering and is now providing advisory services, making it a related party.
• The Sponsor agreed to forfeit an additional 100,000 ordinary shares of ISRL to offset the shares issued to BTIG.
• The cost of the Public Offering of Securities Insurance policy will be split 50% between the Sponsor and NewPubco.

Stakeholder Impact

• Shareholders: Benefit from the resolution of a key condition for the Business Combination, increasing the likelihood of the transaction closing. Face potential dilution from shares issued to BTIG, though mitigated by the Sponsor's forfeiture.
• Israel Acquisitions Sponsor LLC: Incurs the cost of forfeiting 100,000 shares and 50% of the POSI policy, demonstrating commitment to the Business Combination. Gains a potential partner for future SPAC IPOs through BTIG's right of first refusal.
• Gadfin Ltd.: Benefits from the removal of a termination right, allowing the Business Combination to proceed.
• BTIG, LLC: Receives a significant advisory fee ($500,000 cash and 100,000 shares) and a valuable three-year exclusive right of first refusal for future SPAC IPOs, in exchange for waiving deferred underwriting commissions and providing advisory services.
• NewPubco: Will incur 50% of the cost for the Public Offering of Securities Insurance policy.

Next Steps

• Consummation of the Business Combination between ISRL and Gadfin.
• NewPubco to arrange a Public Offering of Securities Insurance policy prior to the closing of the Business Combination.
• BTIG to receive the Advisory Fee and formally waive the Deferred Underwriting Commission upon the closing of the Business Combination.
• BTIG to provide strategic and capital markets advisory services to ISRL.
• ISRL or the Sponsor may undertake future SPAC initial public offerings where BTIG has a right of first refusal.
• Registration of BTIG's shares on the Registration Statement on Form F-4 filed in connection with the Business Combination.

Key Dates

Recommendation

This filing represents a positive step by resolving a critical condition for the proposed business combination and securing essential advisory services, thereby increasing the likelihood of the transaction's completion. For existing shareholders, this removes a significant overhang. However, the filing does not provide new financial or operational data for Gadfin or the combined entity that would warrant a change in investment thesis. A "hold" recommendation is appropriate as investors should await further details on Gadfin's fundamentals and the overall financial projections of the combined company before making a more definitive investment decision.

Keywords

SPAC, Business Combination, Merger, Advisory Agreement, Deferred Underwriting Commission, Capital Markets, Corporate Governance, Risk Management, Israel Acquisitions Corp, Gadfin Ltd, BTIG, NewPubco